Skip to content

Twist Bioscience

US · TWST #1258 by market cap Listed 2018
103.32 -8.30 -7.44%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:52

Price chart

Pre-market 107.41 -3.77%
After-hours 105.01 +1.64%
Overnight 108.44 -2.85%
205.0064.17103.322026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on TWST?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +136.1% on average (3-month/1-year).
  • Main-fund capital flow has been a net outflow over the last 45 sessions.
  • Short interest has fallen to 14.8% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Bearish
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is below the 60-day average, a short-term downtrend.
Quant Rating, last 30 days B → A

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2849 U.S. stocks StockVane covers.

Last computed: 2026-11-21 14:27 UTC

Data coverage: 4 of 6 factors. Missing data is not a zero score.

Overall C+

The radar needs all six factors. Available grades are shown below.

Valuation N/A

How expensive the stock is versus earnings, sales and its own 5-year history.

Not enough data to grade this factor.

Growth N/A

How fast revenue, profit and free cash flow are compounding.

Not enough data to grade this factor.

Profitability D+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 50.7% Better than 64%
Operating margin -36.2% Better than 10%
Net margin -20.6% Better than 12%
Return on equity -16.4% Better than 17%
Return on invested capital -15.6% Better than 15%
Momentum B

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return -29.0% Better than 19%
6-month return 70.6% Better than 98%
12-month return (ex latest month) 374.3% Better than 100%
Distance below 52-week high 53.0% Better than 16%
Financial Health B-

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 3.6x Better than 79%
Debt to assets 11.8% Better than 67%
Interest coverage -7,177.1x Better than 1%
Analyst View A-

What the Street thinks: share of Buy ratings and upside to the average target.

Analysts rating Buy 83.3% Better than 63%
Upside to average target 70.5% Better than 76%

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -7.42%
1M -27.60%
3M -24.21%
6M +92.55%
YTD +225.73%
1Y +296.32%
3Y +317.62%
5Y -6.60%

Key statistics

Price & volume

Prev close
111.62
Open
108.39
Day range
101.00 - 108.50
Avg price
103.98
Volume
3.38M
Turnover
351.44M
Amplitude
6.72%
52-week range
28.27 - 219.71

Valuation

P/E
-49.67
P/E (TTM)
-49.67
P/B
7.71
EPS
-2.08
Net profit
-137.91M
Net assets
888.04M

Share structure

Market cap
6.85B
Float cap
6.77B
Shares out
66.30M
Float shares
65.48M

Dividend & listing

Dividend (TTM)
0.00
Listing date
2018-10-31
52-week range 39% of range
28.27 219.71

53.0% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

-34.76M net over the window

Short interest

Shares short
9.84M
As of
2026-10-30

Frequently asked questions

What is the current stock price of Twist Bioscience (TWST)?

Twist Bioscience last traded at 103.32. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Twist Bioscience's market cap?

About 6.85B.

What is the P/E ratio of Twist Bioscience?

The trailing twelve-month P/E is -49.67. The Valuation tab shows it against the stock's own five-year range.

Does Twist Bioscience pay a dividend?

Twist Bioscience does not currently pay a regular dividend.

Is Twist Bioscience a buy according to analysts?

The consensus of 8 analysts is a Buy rating, with an average 12-month price target of 130.25, which implies 26.1% upside from the current price. This is not investment advice.

What is Twist Bioscience's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Twist Bioscience a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:52:04 · For reference only, not investment advice and not tailored to your situation.

Twist Bioscience discussion 0 comments

Add a comment